SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Johnson & Johnson Prostate Cancer Drug Shrinks Tumors in Early-Stage Trial

Johnson & Johnson reported that its prostate cancer drug shrank tumors in an early-stage trial.

JNJ

Related stories